Vectura Group (VEC) Pharma and Biotech Sector

  • Latest quote

    72.05p (mid)

  • Current Change (%)

    -1.12%

  • Price

    Bid: 71.65p

    Offer: 71.80p

  • Today

    High: 73.65p

    Low: 67.15p

  • This year

    High: 121.50p

    Low: 67.15p

  • Information

    Volume: 946,180

    Market Cap: £479.13M



Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Vectura Group RNS Feed

Title Release date
Update on UK GSK patent litigation 12:34 - December 13, 2018
Block Listing Return 09:44 - December 3, 2018
Total Voting Rights and Capital 09:40 - December 3, 2018
Results for VR475 in severe uncontrolled asthma 07:00 - November 26, 2018
flutiform receives positive opinion in Europe 10:00 - November 9, 2018
Global agreement with Hikma 07:00 - November 8, 2018
Voting Rights and Capital 09:38 - November 1, 2018
Directorate Change 15:00 - October 31, 2018
Vectura Group Employee Benefit Trust 12:59 - October 26, 2018
Director/PDMR Shareholding 16:46 - October 22, 2018
Board Change 07:00 - October 22, 2018
Holdings in Company 17:23 - October 4, 2018
Holding(s) in Company 14:14 - October 2, 2018
Holding(s) in Company 10:13 - October 1, 2018
VOTING RIGHTS AND CAPITAL 10:09 - October 1, 2018

NOTE: This is based on 56 open tips for this company


Total Number of Share tips :

67

View all Vectura Group Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today